JP2011520902A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520902A5
JP2011520902A5 JP2011509674A JP2011509674A JP2011520902A5 JP 2011520902 A5 JP2011520902 A5 JP 2011520902A5 JP 2011509674 A JP2011509674 A JP 2011509674A JP 2011509674 A JP2011509674 A JP 2011509674A JP 2011520902 A5 JP2011520902 A5 JP 2011520902A5
Authority
JP
Japan
Prior art keywords
relaxin
wound
skin
healing
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011509674A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520902A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/043854 external-priority patent/WO2009140433A1/en
Publication of JP2011520902A publication Critical patent/JP2011520902A/ja
Publication of JP2011520902A5 publication Critical patent/JP2011520902A5/ja
Pending legal-status Critical Current

Links

JP2011509674A 2008-05-16 2009-05-13 創傷の治癒を促進する方法 Pending JP2011520902A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12794708P 2008-05-16 2008-05-16
US61/127,947 2008-05-16
PCT/US2009/043854 WO2009140433A1 (en) 2008-05-16 2009-05-13 Method of promoting wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014039200A Division JP2014129392A (ja) 2008-05-16 2014-02-28 創傷の治癒を促進する方法

Publications (2)

Publication Number Publication Date
JP2011520902A JP2011520902A (ja) 2011-07-21
JP2011520902A5 true JP2011520902A5 (enExample) 2012-06-28

Family

ID=41319048

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011509674A Pending JP2011520902A (ja) 2008-05-16 2009-05-13 創傷の治癒を促進する方法
JP2014039200A Pending JP2014129392A (ja) 2008-05-16 2014-02-28 創傷の治癒を促進する方法
JP2016092656A Pending JP2016179990A (ja) 2008-05-16 2016-05-02 創傷の治癒を促進する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014039200A Pending JP2014129392A (ja) 2008-05-16 2014-02-28 創傷の治癒を促進する方法
JP2016092656A Pending JP2016179990A (ja) 2008-05-16 2016-05-02 創傷の治癒を促進する方法

Country Status (10)

Country Link
US (2) US20100041603A1 (enExample)
EP (1) EP2278993A4 (enExample)
JP (3) JP2011520902A (enExample)
CN (2) CN105688192A (enExample)
AU (1) AU2009246333B2 (enExample)
BR (1) BRPI0912560A2 (enExample)
CA (1) CA2724308C (enExample)
MX (1) MX2010012454A (enExample)
RU (1) RU2506092C2 (enExample)
WO (1) WO2009140433A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104159594A (zh) * 2011-10-13 2014-11-19 托马斯·盖德克 用于皮肤病治疗的凯莫瑞c15肽的局部制剂
CA2878516A1 (en) * 2012-07-31 2014-02-06 Novartis Ag Treating inflammation using serelaxin
WO2015044788A1 (en) * 2013-09-26 2015-04-02 Galderma S.A. Prostaglandin f2alpha and analogues thereof for treating atrophic cutaneous scarring
KR20180006362A (ko) * 2014-12-09 2018-01-17 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 조직 치유 및 수복을 촉진하는 방법
PT3387019T (pt) 2015-12-09 2022-01-14 Scripps Research Inst Proteínas de fusão de imunoglobulina de relaxina e métodos de uso
JP6955736B2 (ja) * 2016-09-14 2021-10-27 ヤンマーパワーテクノロジー株式会社 水生生物の飼育装置
US10266578B2 (en) 2017-02-08 2019-04-23 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3003917A (en) * 1959-01-14 1961-10-10 Nat Drug Co Wound healing composition
CH661662A5 (en) * 1984-04-16 1987-08-14 Georg L Prof Dr Floersheim Product for the treatment of the skin and of the connective tissue
US4863733A (en) * 1985-08-28 1989-09-05 Startz Jack P Method of preparing treatment compositions for use in plastic or cosmetic surgery
JP2815649B2 (ja) * 1988-02-26 1998-10-27 ジェネンテク，インコーポレイテッド ヒトレラキシン製剤
US4969880A (en) * 1989-04-03 1990-11-13 Zamierowski David S Wound dressing and treatment method
US5100396A (en) * 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
WO1996033733A1 (en) * 1995-04-25 1996-10-31 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel remedy for skin deficiencies
DE69624925T2 (de) * 1995-08-15 2003-09-04 Connetics Corp., Palo Alto Verwendung von relaxin zur stimulierung der angiogenese
US6176854B1 (en) * 1997-10-08 2001-01-23 Robert Roy Cone Percutaneous laser treatment
US7550143B2 (en) * 2005-04-06 2009-06-23 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
US7534866B2 (en) * 2005-10-19 2009-05-19 Ibc Pharmaceuticals, Inc. Methods and compositions for generating bioactive assemblies of increased complexity and uses
DE60128540T2 (de) * 2000-02-09 2008-01-31 Bas Medical, Inc., San Mateo Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen
AU2002324727A1 (en) * 2001-08-17 2003-03-03 The Board Of Trustees Of The Leland Stanford Junior University Mammalian relaxin receptors
CA2468826C (en) * 2001-12-07 2011-11-01 Applied Research Systems Ars Holding N.V. Benzazole derivatives for the treatment of scleroderma
US7591994B2 (en) * 2002-12-13 2009-09-22 Immunomedics, Inc. Camptothecin-binding moiety conjugates
US8877901B2 (en) * 2002-12-13 2014-11-04 Immunomedics, Inc. Camptothecin-binding moiety conjugates
AU2003216375A1 (en) * 2002-02-28 2003-09-16 Immunex Corporation Rank-ligand-induced sodium/proton antiporter polypeptides
JP4959136B2 (ja) * 2002-12-13 2012-06-20 イミューノメディクス、インコーポレイテッド 細胞内で開裂可能な結合を有する免疫接合体
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US7738952B2 (en) * 2003-06-09 2010-06-15 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system
US7149574B2 (en) * 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
US20050153885A1 (en) * 2003-10-08 2005-07-14 Yun Anthony J. Treatment of conditions through modulation of the autonomic nervous system
US8569277B2 (en) * 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
EP1846443A4 (en) * 2005-01-07 2008-07-23 Glaxo Group Ltd NEW USE
CA2604032C (en) * 2005-04-06 2017-08-22 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
CN101534865A (zh) * 2005-10-19 2009-09-16 Ibc药品公司 生物活性装配体的制备方法及其用途
CN102871857A (zh) * 2005-12-15 2013-01-16 卢塞迪奥·格莱西 新型氮氧化物抗氧化剂的合成和在化妆用和皮肤病用组合物中的使用方法

Similar Documents

Publication Publication Date Title
Friedmann et al. Combination of intense pulsed light, Sculptra, and Ultherapy for treatment of the aging face.
Chandrashekar et al. Alopecia areata—successful outcome with microneedling and triamcinolone acetonide
MX2022004278A (es) Aspecto cosmetico de la piel.
JP2015512418A5 (enExample)
CN105310734B (zh) 涂敷有金属的带刺缝线
EP2968885A1 (en) Apparatus and method for tissue rejuvenation
NZ586302A (en) Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising
NZ591037A (en) Wound healing using choroid plexus secreted proteins
JP2016501866A5 (enExample)
RU2010151472A (ru) Способ активирования лечения ран
EP2407147A3 (en) Composition with bio-rigenerative, restorative and eutrophying activity
CN107029219B (zh) 一种促进皮肤组织再生的药膏
RU175719U1 (ru) Многослойная косметологическая маска с наполнителем
WO2016081296A3 (en) Topical medicament for skin and mucosal injuries associated with epidermolisis bullosa
Drogovoz et al. Application of carboxytherapy in dermatology
BARBOSA et al. Efficacy Of Polydioxanone Threads For The Treatment Of Facial Sagging: Case Report
Mozafarpoor et al. Fractional ablative Er: YAG laser therapy in a patient with chronic recessive dystrophic epidermolysis bullosa: a case report and review of literature
Chung et al. Aesthetic soft tissue management in facial trauma
Mauricio Combining Hydradermabrasion with Aesthetic Treatments
CN103830142A (zh) 一种滋养美白中药面膜及其制备方法
CN201823085U (zh) 一种用于治疗浅静脉炎的贴片
Branham et al. Advances in Cosmetic Surgery, E-Book 2023: Advances in Cosmetic Surgery, E-Book 2023
Smithies Non-invasive facial treatments–The new approach
CN203885715U (zh) 一种面瘫膏药贴
Cardoso et al. Electrosurgery in the treatment of giant rhinophyma: a case report